rifampin and Serositis

rifampin has been researched along with Serositis* in 1 studies

Other Studies

1 other study(ies) available for rifampin and Serositis

Article	Year
Preliminary observations on short-course chemotherapy in tuberculous serositis. Respiration; international review of thoracic diseases, 1984, Volume: 46, Issue:1 Short-course chemotherapy has not been previously assessed in tuberculous serositis. In this study, 18 patients with tuberculous serositis were studied. 600 mg of rifampicin, 300 mg of isoniazid and 25 mg of pyridoxine were given daily for 6 months. 14 patients completed the therapeutic regimen and were evaluated. 11 of these showed excellent results on the long-term follow-up (18-24 months) and 3 of shorter-term follow-up (9-12 months). Short-course chemotherapy appears to be efficacious in the treatment of tuberculous serositis. However, further and larger trials are recommended. Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyridoxamine; Rifampin; Serositis; Time Factors; Tuberculosis	1984

Article

Year

Preliminary observations on short-course chemotherapy in tuberculous serositis.

Respiration; international review of thoracic diseases, 1984, Volume: 46, Issue:1

Short-course chemotherapy has not been previously assessed in tuberculous serositis. In this study, 18 patients with tuberculous serositis were studied. 600 mg of rifampicin, 300 mg of isoniazid and 25 mg of pyridoxine were given daily for 6 months. 14 patients completed the therapeutic regimen and were evaluated. 11 of these showed excellent results on the long-term follow-up (18-24 months) and 3 of shorter-term follow-up (9-12 months). Short-course chemotherapy appears to be efficacious in the treatment of tuberculous serositis. However, further and larger trials are recommended.

Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Pyridoxamine; Rifampin; Serositis; Time Factors; Tuberculosis

1984